Lindbrook Capital, LLC - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 64 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q4 2021$21,000
+10.5%
610
+18.9%
0.00%
-40.0%
Q3 2021$19,000
-5.0%
5130.0%0.01%
+25.0%
Q2 2021$20,000
+17.6%
513
-14.6%
0.00%0.0%
Q1 2021$17,000
-10.5%
6010.0%0.00%
-20.0%
Q4 2020$19,0000.0%601
+0.8%
0.01%0.0%
Q3 2020$19,000
+18.8%
596
+2.9%
0.01%0.0%
Q2 2020$16,000
+128.6%
579
+44.4%
0.01%
+66.7%
Q1 2020$7,0004010.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GENERAL ATLANTIC, L.P. 4,000,000$67,760,0001.05%
M&G INVESTMENT MANAGEMENT LTD 7,084,834$120,442,1780.54%
Bellevue Group AG 1,802,963$30,584,7610.49%
AIA Group Ltd 391,278$6,628,2490.32%
PLATINUM INVESTMENT MANAGEMENT LTD 182,052$3,083,9610.12%
SCHRODER INVESTMENT MANAGEMENT GROUP 4,219,168$71,472,7060.11%
Hennion & Walsh Asset Management, Inc. 51,735$876,3910.06%
Allianz Asset Management GmbH 1,644,999$27,866,2830.05%
Janney Capital Management LLC 17,203$2910.02%
ACADIAN ASSET MANAGEMENT LLC 193,811$3,2680.01%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders